second half of 202122 Jan 2021 09:19
So the window for completion has been tightened from 12 months from Dec 20, to 6 months in Jan 21. Although first half of 21 was way too much to be hoped, its good to have a clearer anticipated target with a fully operational machine, clinically approved to full speed.
Without schedule slippage, and no further dilution, this should see a significant sp increase this year. Will we see a sudden multibag increase or a gradual rise. Initial sales will probably be treated with caution based on historical 'sales' announcements. What indicators will there be for the clinical approval? Will we start to see activities around the location for the first patient? Where exactly is that first location? Daresbury/Pebble Mill/Harley St?
Anyone care to guess at the s.p. with a fully clinically operational machine assuming the new guidance is accurate? A filled out order book, actual machine deliveries, patients being treated, income from the aftermarket are all yet to come, but what value do we put on this first key stage of moving from prototype to first model?